Jeffrey J. Rice received his Ph.D. in Chemical Engineering from the University of California, Santa Barbara in 2007 where he engineered protein display techniques to discover novel therapeutic peptides. After which he played a major role in transitioning the technology for industrial use as a research scientist at CytomX Therapeutics, Inc. Currently, he is an assistant professor at the Tennessee Technological University carrying out research in the area of protein and biological engineering. Before beginning his faculty position, he was a Whitaker post-doctoral research fellow in the Laboratory for Regenerative Medicine and Pharmacobiology at the École Polytechnique Fédérale de Lausanne working under Professor Jeff Hubbell. His research focuses on applying protein engineering techniques to modify extracellular matrix proteins and growth factors to study angiogenesis and gene delivery for enhanced tissue repair and regeneration.